Virtual Residency Showcase, psilocybin results, Walgreens removes speed metrics, and more!
Update: 2022-11-04
Description
This week on Pharm5:
- SNPhA x ACCP Residency Showcase
- Amoxicillin suspension shortage
- Psilocybin for episodes of major depression
- RSV vaccine trials
- Walgreens removes speed metrics
Connect with us!
- Listen to our podcast: Pharm5
- Follow us on Twitter: @LizHearnPharmD
References:
- SNPhA x ACCP Residency and Fellowship Showcase. ACCP. https://bit.ly/3fyqSrQ. Accessed November 3, 2022.
- Weixel N. FDA reports shortages of amoxicillin. The Hill. https://bit.ly/3fsEODL. Published November 1, 2022. Accessed November 3, 2022.
- Amoxil. Package Insert. GlaxoSmithKline; 2006.
- FDA drug shortages. FDA Drug Shortages. https://bit.ly/3UlvAb5. Accessed November 3, 2022.
- Goodwin GM, Aaronson ST, Alvarez O, et al. Single-dose psilocybin for a treatment-resistant episode of Major Depression. New England Journal of Medicine. 2022;387(18):1637-1648. doi:10.1056/nejmoa2206443
- RSV vaccine protects babies from severe infections, Pfizer study finds. The Wall Street Journal. https://on.wsj.com/3UgNAna. Published November 1, 2022. Accessed November 3, 2022.
- Pfizer Announces Positive Top-Line Data of Phase 3 Global Maternal Immunization Trial for its Bivalent Respiratory Syncytial Virus (RSV) Vaccine Candidate. https://bit.ly/3FFuh2v. Accessed November 3, 2022.
- Walgreens sharpens focus on patient care and experience, eliminating task-based metrics for Pharmacy Staff Performance Reviews Chainwide. Walgreens Newsroom. https://bit.ly/3t1TdcU. Accessed November 3, 2022.
- Walgreens will stop judging its pharmacy staff by how fast they work. NBCNews.com. https://nbcnews.to/3zGXvKA. Published October 28, 2022. Accessed November 3, 2022.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
